81 – 90 of 158
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Prediction of outcome after diagnosis of metachronous contralateral breast cancer
Alkner, Sara LU ; Bendahl, Pär-Ola LU ; Fernö, Mårten LU ; Manjer, Jonas LU and Ryden, Lisa LU
(2010)
San Antonio Breast Cancer Symposium 2010
In Cancer Research
70(Issue 24 suppl).
- Contribution to journal › Published meeting abstract
- 2009
-
Mark
No positive effect of postmastectomy radiotherapy on mortality at 20 years in pre menopausal women with stage II breast cancer also treated with adjuvant oral cyclophopsphamide. South Sweden Breast Cancer Group, trial SBII:I
- Contribution to journal › Published meeting abstract
-
Mark
TIMP-1 and responsiveness of estrogen receptor negative breast cancer to preoperative epirubicin and cyclophosphamide with or without gefitinib
- Contribution to journal › Published meeting abstract
-
Mark
Vascular endothelial growth factor receptor 2 is a significant negative prognostic biomarker in triple-negative breast cancer: results from a controlled randomised trial of premenopausal breast cancer
Rydén, Lisa LU
; Fernö, Mårten
LU
; Stal, O
; Linderholm, B.
; Ostman, A
and Jirström, Karin
LU
(2009)
31st Annual San Antonio Breast Cancer Symposium
In Cancer Research
69(2).
p.132-132
- Contribution to journal › Published meeting abstract
-
Mark
Significantly higher expression of vascular endothelial growth factor (VEGF) and shorter survival after recurrences in premenopausal node negative patients with triple negative breast cancer
- Contribution to journal › Published meeting abstract
-
Mark
Validation of the predictive value of tissue inhibitor of metalloproteinases-1 for the response to first-line chemotherapy in metastatic breast cancer.
- Contribution to journal › Published meeting abstract
-
Mark
Pentoxifylline and Vitamin E Treatment for Prevention of Radiation Induced Side Effects in Women with Breast Cancer: A Phase Two, Double Blind, Placebo Controlled Randomised Clinical Trial (Ptx-5)
- Contribution to journal › Published meeting abstract
-
Mark
Cyclin B1 Is an Independent Prognostic Proliferation Marker with a High Reproducibility in a Population-Based Lymph Node Negative Breast Cancer Cohort
- Contribution to journal › Published meeting abstract
-
Mark
Long-Term Survival of Breast Ductal Carcinoma In Situ in Women with Different Gene-Expression Types.
Zhou, W. ; Johansson, C. ; Jirström, Karin LU
; Olorunsola, A.
; Garmo, H.
and Warnberg, F.
(2009)
32nd Annual San Antonio Breast Cancer Symposium
In Cancer Research
69(24).
p.629-630
- Contribution to journal › Published meeting abstract
-
Mark
Do We Need Axillary Staging for All Breast Cancers? A Cohort Study from Sweden. The Natural Course of Small Breast Cancer.
- Contribution to journal › Published meeting abstract